June 17, 2019
PMDA Committee on Review and Safety Operations on June 14 The Pharmaceuticals and Medical Devices Agency (PMDA) will exchange opinions with scientific societies and drug makers on how best to use Shionogi’s anti-influenza drug Xofluza (baloxavir marboxil) in response to...read more